CD123-targeted therapy in acute myeloid leukemia.
Manuel Ricardo Espinoza-GutarraSteven D GreenJoshua F ZeidnerHeiko KonigPublished in: Expert review of hematology (2021)
CD123 represents a suitable therapeutic target that has the potential to improve AML patient outcomes.